Gut microbiota and colorectal cancer

The gut microbiota is considered as a forgotten organ in human health and disease. It maintains gut homeostasis by various complex mechanisms. However, disruption of the gut microbiota has been confirmed to be related to gastrointestinal diseases such as colorectal cancer, as well as remote organs in many studies. Colorectal cancer is a multi-factorial and multi-stage involved disorder. The role for microorganisms that initiate and facilitate the process of colorectal cancer has become clear. The candidate pathogens have been identified by culture and next sequencing technology. Persuasive models have also been proposed to illustrate the complicated and dynamic time and spatial change in the carcinogenesis. Related key molecules have also been investigated to demonstrate the pathways crucial for the development of colorectal cancer. In addition, risk factors that contribute to the tumorigenesis can also be modulated to decrease the susceptibility for certain population. In addition, the results of basic studies have also translated to clinical application, which displayed a critical value for the diagnosis and therapy of colorectal cancer. In this review, we not only emphasize the exploration of the mechanisms, but also potential clinical practice implication in this microbiota era.

[1]  S. Larsson,et al.  Diabetes mellitus and risk of colorectal cancer: a meta-analysis. , 2005, Journal of the National Cancer Institute.

[2]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[3]  H. Sokol,et al.  Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease , 2015, Gut.

[4]  Tomas Hrncir,et al.  Nod2 is required for the regulation of commensal microbiota in the intestine , 2009, Proceedings of the National Academy of Sciences.

[5]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[6]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[7]  P. Laird,et al.  Association between molecular subtypes of colorectal cancer and patient survival. , 2015, Gastroenterology.

[8]  D. Philpott,et al.  Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis , 2013, Gut microbes.

[9]  M. Meyerson,et al.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.

[10]  Bas E Dutilh,et al.  A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects , 2012, Nature Reviews Microbiology.

[11]  K. Strissel,et al.  Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice , 2014, The ISME Journal.

[12]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[13]  B. Weimer,et al.  Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line , 2013, Scientific Reports.

[14]  P. Gibson,et al.  Diets that differ in their FODMAP content alter the colonic luminal microenvironment , 2014, Gut.

[15]  M. R. Rubinstein,et al.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.

[16]  É. Oswald,et al.  Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria , 2015, Gut.

[17]  H. Qin,et al.  Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer. , 2015, Molecular medicine reports.

[18]  A. Weintraub,et al.  Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Hiromu Suzuki,et al.  Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway , 2015, International journal of cancer.

[20]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[21]  Jarkko Salojärvi,et al.  Effects of bowel cleansing on the intestinal microbiota , 2014, Gut.

[22]  P. Schloss,et al.  The Human Gut Microbiome as a Screening Tool for Colorectal Cancer , 2014, Cancer Prevention Research.

[23]  Cynthia L Sears,et al.  A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses , 2009, Nature Medicine.

[24]  D. Philpott,et al.  Commensal and Probiotic Bacteria Influence Intestinal Barrier Function and Susceptibility to Colitis in Nod1−/−;Nod2−/− Mice , 2012, Inflammatory bowel diseases.

[25]  Jun Yu,et al.  Gut mucosal microbiome across stages of colorectal carcinogenesis , 2015, Nature Communications.

[26]  W. D. de Vos,et al.  Impact of diet on human intestinal microbiota and health. , 2014, Annual review of food science and technology.

[27]  Lennart Sjöberg,et al.  Ahlstrand E , Persson L , Tidefelt U , Söderquist B. Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy. Eur J Clin Microbiol Infect Dis , 2011 .

[28]  S. Spanò,et al.  A Bacterial Pathogen Targets a Host Rab-Family GTPase Defense Pathway with a GAP. , 2016, Cell host & microbe.

[29]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[30]  E. Elinav,et al.  NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells , 2012, Nature.

[31]  D. Golenbock,et al.  Induction of Persistent Colitis by a Human Commensal, Enterotoxigenic Bacteroides fragilis, in Wild-Type C57BL/6 Mice , 2009, Infection and Immunity.

[32]  C. Alpuche-Aranda,et al.  This information is current as Activation and Cell Death Cells by Preventing Inflammasome Expression To Promote Its Survival in B Family CARD Domain Containing Protein 4 Downregulates Nod-like Receptor Salmonella , 2013 .

[33]  M. Toyota,et al.  Fusobacterium in colonic flora and molecular features of colorectal carcinoma. , 2014, Cancer research.

[34]  D. Philpott,et al.  Nod-like proteins in immunity, inflammation and disease , 2006, Nature Immunology.

[35]  D. Pezet,et al.  Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. , 2014, World journal of gastroenterology.

[36]  Nathalie M. Delzenne,et al.  Towards a more comprehensive concept for prebiotics , 2015, Nature Reviews Gastroenterology &Hepatology.

[37]  P. Goldberg,et al.  Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopathological Features of Colorectal Cancer , 2015, PloS one.

[38]  Jesse D. Martinez,et al.  Differential Regulation of EGFR–MAPK Signaling by Deoxycholic Acid (DCA) and Ursodeoxycholic Acid (UDCA) in Colon Cancer , 2014, Digestive Diseases and Sciences.

[39]  M. Delledonne,et al.  Deciphering bifidobacterial-mediated metabolic interactions and their impact on gut microbiota by a multi-omics approach , 2016, The ISME Journal.

[40]  Justine W. Debelius,et al.  Specialized metabolites from the microbiome in health and disease. , 2014, Cell metabolism.

[41]  C. Sears,et al.  Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis , 2010, Cell cycle.

[42]  H. Harmsen,et al.  Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses , 2016, Scientific Reports.

[43]  E. Murphy,et al.  Exercise and associated dietary extremes impact on gut microbial diversity , 2014, Gut.

[44]  S. Sørensen,et al.  Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial. , 2014, FEMS microbiology ecology.

[45]  W. Marlicz,et al.  The effect of exercise and diet on gut microbial diversity , 2014, Gut.

[46]  S. Jonjić,et al.  Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. , 2015, Immunity.

[47]  Gabriel Núñez,et al.  Intracellular NOD-like receptors in host defense and disease. , 2007, Immunity.

[48]  S. Park,et al.  Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination , 2013, Oncogene.

[49]  Qiang Feng,et al.  Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer , 2015, Gut.

[50]  M. Hornef,et al.  Real friends: Faecalibacterium prausnitzii supports mucosal immune homeostasis , 2015, Gut.

[51]  C. Sears,et al.  The toxins of Bacteroides fragilis. , 2001, Toxicon : official journal of the International Society on Toxinology.

[52]  T. Weir,et al.  Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. , 2015, Cell host & microbe.

[53]  E. Allen-Vercoe,et al.  Fusobacterium nucleatum Infection of Colonic Cells Stimulates MUC2 Mucin and Tumor Necrosis Factor Alpha , 2011, Infection and Immunity.

[54]  F. Ginhoux,et al.  Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota , 2015, Science.

[55]  Cynthia L Sears,et al.  Microbes, microbiota, and colon cancer. , 2014, Cell host & microbe.

[56]  Paolo Vineis,et al.  Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. , 2005, Journal of the National Cancer Institute.

[57]  M. Donnenberg,et al.  An Escherichia coli Effector Protein Promotes Host Mutation via Depletion of DNA Mismatch Repair Proteins , 2013, mBio.

[58]  P. Godowski,et al.  Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.

[59]  Lawrence A. David,et al.  Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.

[60]  C. Xiang,et al.  Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer , 2012, PloS one.

[61]  Taro Kawai,et al.  Toll-Like Receptor Signaling Pathways , 2014, Front. Immunol..

[62]  S. Akira,et al.  Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.

[63]  B. Peleteiro,et al.  Dietary patterns and colorectal cancer: systematic review and meta-analysis , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[64]  Belgin Dogan,et al.  Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.

[65]  Mathieu Almeida,et al.  Dietary intervention impact on gut microbial gene richness , 2013, Nature.

[66]  Haitao Wen,et al.  Mechanisms of NOD-like receptor-associated inflammasome activation. , 2013, Immunity.

[67]  David A. Relman,et al.  Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota , 2012, Cell.

[68]  Jason B. Williams,et al.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.

[69]  Ruth Ley,et al.  Unravelling the effects of the environment and host genotype on the gut microbiome , 2011, Nature Reviews Microbiology.

[70]  Patrick D Schloss,et al.  Structure of the gut microbiome following colonization with human feces determines colonic tumor burden , 2014, Microbiome.

[71]  J. Raisch,et al.  Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression , 2015, Laboratory Investigation.

[72]  Emmanuel Buc,et al.  Colonization of the Human Gut by E. coli and Colorectal Cancer Risk , 2013, Clinical Cancer Research.

[73]  C. Hart,et al.  Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. , 2004, Gastroenterology.

[74]  Jan Verhaegen,et al.  A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis , 2013, Gut.

[75]  F. Gusovsky,et al.  Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction* , 1999, The Journal of Biological Chemistry.

[76]  J. Crawford,et al.  The colibactin warhead crosslinks DNA , 2015, Nature chemistry.

[77]  C. Hart,et al.  A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli. , 2008, Microbiology.

[78]  Alicja Wolk,et al.  Meat consumption and risk of colorectal cancer: A meta‐analysis of prospective studies , 2006, International journal of cancer.

[79]  J. Goedert,et al.  Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.

[80]  Elhanan Borenstein,et al.  Extensive Strain-Level Copy-Number Variation across Human Gut Microbiome Species , 2015, Cell.

[81]  M. Ebert,et al.  Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[82]  T. Giese,et al.  Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.

[83]  Stephanie A. Bien,et al.  Genetic architecture of colorectal cancer , 2015, Gut.

[84]  D. Douek,et al.  Microbial translocation across the GI tract. , 2012, Annual review of immunology.

[85]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Herbert Tilg,et al.  Gut microbiome development along the colorectal adenoma-carcinoma sequence , 2015 .

[87]  G. Hajishengallis,et al.  The keystone-pathogen hypothesis , 2012, Nature Reviews Microbiology.

[88]  S. Pettersson,et al.  Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. , 2012, Carcinogenesis.

[89]  C. Huttenhower,et al.  Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. , 2015, JAMA oncology.

[90]  J. Parkhill,et al.  Modulation of the human gut microbiota by dietary fibres occurs at the species level , 2016, BMC Biology.

[91]  D. Pezet,et al.  High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer , 2013, PloS one.

[92]  A. Israël,et al.  Invasive Shigella flexneri Activates NF-κB Through a Lipopolysaccharide-Dependent Innate Intracellular Response and Leads to IL-8 Expression in Epithelial Cells1 , 2000, The Journal of Immunology.

[93]  Y. Iwakura,et al.  Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis. , 2014, Immunity.

[94]  W. Thabet,et al.  Enteropathogenic Escherichia coli (EPEC): Does it have a role in colorectal tumourigenesis? A Prospective Cohort Study. , 2015, International journal of surgery.

[95]  Patrice D. Cani,et al.  Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling , 2015, Cell metabolism.

[96]  D. Brenner,et al.  Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation. , 2016, Cell host & microbe.

[97]  D. Šmajs,et al.  Escherichia colistrains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia , 2014, BMC Infectious Diseases.

[98]  F. Ryan,et al.  Tumour-associated and non-tumour-associated microbiota in colorectal cancer , 2016, Gut.

[99]  Liping Zhao,et al.  Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers , 2011, The ISME Journal.

[100]  J. Petrosino,et al.  The Gut Microbiome Modulates Colon Tumorigenesis , 2013, mBio.

[101]  C. Sears,et al.  Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. , 2014, The Journal of clinical investigation.

[102]  Mingyang Song,et al.  Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis , 2015, Gut.

[103]  H. Qin,et al.  Microbiota disbiosis is associated with colorectal cancer , 2015, Front. Microbiol..

[104]  T. Pischon,et al.  Obesity and colorectal cancer. , 2013, Frontiers in bioscience.

[105]  G. Núñez,et al.  Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens. , 2016, Immunity.

[106]  A. Gupta,et al.  Streptococcus bovis endocarditis, a silent sign for colonic tumour , 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[107]  Jens Roat Kultima,et al.  Potential of fecal microbiota for early‐stage detection of colorectal cancer , 2014 .

[108]  Martyn F. Symmons,et al.  Assembly and localization of Toll-like receptor signalling complexes , 2014, Nature Reviews Immunology.

[109]  Jun Yu,et al.  Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment , 2015, Oncotarget.

[110]  Yongzhi Yang,et al.  Analysis of the Intestinal Lumen Microbiota in an Animal Model of Colorectal Cancer , 2014, PloS one.

[111]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[112]  A. Bull,et al.  Microbial diversity , 2004, Biodiversity & Conservation.

[113]  Cynthia L Sears,et al.  Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. , 2001, Gastroenterology.

[114]  James Kinross,et al.  The gut microbiota and host health: a new clinical frontier , 2015, Gut.

[115]  Yu-Xiao Yang,et al.  Cholecystectomy and the Risk of Colorectal Cancer , 2005, The American Journal of Gastroenterology.

[116]  Nod2: a key regulator linking microbiota to intestinal mucosal immunity , 2011, Journal of Molecular Medicine.

[117]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[118]  A. Aderem,et al.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.

[119]  D. Green,et al.  The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. , 2011, Cancer cell.

[120]  Seunghyung Lee,et al.  Bacteroides fragilis Toxin Induces IL-8 Secretion in HT29/C1 Cells through Disruption of E-cadherin Junctions , 2013, Immune network.

[121]  Tianhui Chen,et al.  National estimates of cancer prevalence in China, 2011. , 2016, Cancer letters.

[122]  Gabriel Cuevas-Ramos,et al.  Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells , 2010, Proceedings of the National Academy of Sciences.

[123]  Tarah Lynch,et al.  Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host , 2011, Inflammatory bowel diseases.

[124]  N. Barnich,et al.  Gut microbiota imbalance and colorectal cancer. , 2016, World journal of gastroenterology.

[125]  Gabriel Núñez,et al.  Control of pathogens and pathobionts by the gut microbiota , 2013, Nature Immunology.

[126]  B. Birren,et al.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.

[127]  D. Sinderen,et al.  Gut microbiota composition correlates with diet and health in the elderly , 2012, Nature.